Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

HISTORICAL FACTS: Paul burton - Caught on Camera

Plan for $1.5bn Trump Tower on Gold Coast scrapped because brand ‘toxic to Australians’

The Surfers Paradise development has been abandoned with Altus Property Group and the Trump Organization blaming each other

The Guardian - AU

Will a Trump Tower finally rise in Australia – or is this more flash and bluster on the Gold Coast glitter strip?

Previous plans for a Trump Tower in Queensland almost 20 years ago went the way of other imagined edifices in Rio, Batumi and Tijuana

The Guardian - AU

'I thought, this is going to be close': How two riders broke a 47-year-old time trial record almost simultaneously – 150 miles apart

Another success story for road bike time trials in the UK as Alf Engers's 1978 25-mile mark is soundly beaten

Cycling Weekly

From analysis to the latest developments in health,
read the most diverse news in one place.

24 Hours in Police Custody review – a staggering journey into the heart of an armed siege

This extended look at a gun-based standoff is stark, emotional TV which says as much about policing as the UK’s mental-health crisis. It’s quite a step-change from tidings of comfort and joy

The Guardian - UK

Former Covid medical officer Van-Tam takes role at vaccine maker Moderna

One of UK’s public faces of pandemic, ‘JVT’ was known for football-related metaphors in No 10 briefings

The Guardian - UK

Housing crisis pushing more Tasmanians into unusual accommodation

From caravans to sheds and even yurts, a wide variety of dwellings are being touted as viable home options on online sale platforms.

ABC News

Cancer and heart disease vaccines could be ready 'by the end of the decade'

The speed of which the Covid jab was developed has "unspooled" medical advancements

Wales Online

Read news from The Economist, FT, and more,
with one subscription

Vaccines for cancer could be ready by 2030, according to Moderna chief

The pharmaceutical firm said it is confident the jabs for cancer could be ready by the end of the decade

Manchester Evening News

Cancer and heart disease vaccines ‘ready by end of the decade’

Exclusive: Pharmaceutical firm says groundbreaking jabs could save millions of lives

The Guardian - UK

Cannabis campaigners' 'malicious prosecution' case concludes after two days

Court clashes in medicinal cannabis suppression order case

Newcastle Herald

Lisa Jarvis: Cancer vaccine hunt makes progress, finally

The long-awaited cancer vaccine revolution is getting a little closer to reality. New data from Moderna Inc. and Merck & Co. suggest that after decades of failures, researchers are finally figuring out the right way to design a vaccine that can teach immune cells how to recognize and combat tumors.

Tribune News Service

New covid jag approved by UK to specifically target Omicron will be fourth vaccine

Moderna’s chief medical officer, Dr Paul Burton, previously said that the new jag can boost a person’s antibodies to such high levels that it may only be needed once per year.

Daily Record

UK becomes first country to approve new Covid jab specifically targeting Omicron

Moderna's chief medical officer, Dr Paul Burton, previously said that the new jab can boost a person's antibodies to such high levels that it may only be needed annually

Daily Mirror

New 'super booster' Covid vaccine could be approved for use in UK within days

Moderna has created a new type of jab, codenamed 214, which is said to be more effective than previous vaccines, according to reports

Chronicle Live

Get all your
news in one place.

100's of premium titles.
One news app.

Wales Online

30million people could get new Covid super booster codenamed 214

The jab engineered to tackle the new variants causing a summer wave is expected to be approved for use in the UK

Daily Record

Moderna confirms two-in-one Covid and flu jab in the works as testing under way

Scientists have developed an alternative to the current separate inoculations with the trial already under

Daily Mirror

Young adults and children should get Covid booster jabs this autumn, vaccine chiefs warn

The announcement comes after the UK is seeing a spike in Covid-19 cases and follows a trial of Moderna's new vaccine designed to tackle the more contagious sub-variants of Omicron

Wales Online

Two-in-one covid and flu jab in pipeline with testing under way

Vaccination developer Moderna is calling for action on the current jab programme warning people could find themselves 'under-protected and under-vaccinated'

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

Moderna to build UK’s first mRNA vaccine research and manufacturing centre

US biotech firm agrees £1bn deal with government for centre to combat Covid and other illnesses

The Independent UK

Call for autumn booster programme to be extended

It comes as Moderna announced that its variant vaccine can create a strong antibody response to the BA.4 and the BA.5 variants.

ABC News

COVID-19 vaccine from Moderna 'provides good clinical protection' against Omicron subvariants

The biotech company's experimental Omicron booster generates high levels of antibodies that neutralise subvariants BA.4 and BA.5, according to preliminary clinical trial data.

The Guardian - UK

Trials of new COVID vaccine raise hopes of once-a-year booster

Moderna shot is said to produce eightfold increase in antibody levels against Omicron in first four weeks

The Independent UK

Moderna vaccine trial raises hopes of yearly Covid booster

People who received vaccine showed significant jump in antibody levels compared to original Moderna jab

Tribune News Service

Moderna’s omicron-targeted shot bolsters antibodies in trial

Moderna Inc. said its COVID-19 vaccine that targets omicron generated a “superior” immune response against the variant compared to its original shot in a widely awaited study that could pave the way for another round of boosters in the fall.

Benzinga

Moderna Bullish On COVID-19 Vaccine For Younger Kids To Be Ready Next Month: Reuters

Moderna Inc's (NASDAQ:MRNA) chief medical officer said that its COVID-19 vaccine for children under six years old would be ready for review by the FDA panel when it meets in June. "I think the FDA now has all of the core fundamental data they need to be able to begin an application review.…

1 2

People

Michael CouttsTrotter

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Trump Organization

Medicines and Healthcare products Regulatory Agency

23 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.